Methotrexate promotes glucose uptake and lipid oxidation in skeletal muscle via AMPK activation

Methotrexate (MTX) is a widely used anti-cancer and anti-rheumatic drug that has been postulated to protect against metabolic risk factors associated with type 2 diabetes mellitus, although the mechanism remains unknown. MTX inhibits 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase /...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Diabetes
Prif Awduron: Pirkmajer, Sergej, Kulkarni, Sameer S., Tom, Robby Z., Fyffe, Fiona A., Hawley, Simon A., Hardie, D. Grahame, Zierath, Juleen R., Chibalin, Alexander V.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5703413/
https://ncbi.nlm.nih.gov/pubmed/25338814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db14-0508
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg